IBHF ETF Analysis: iBonds 2026 Term High Yield | BATS
Target Maturity Bonds | BATS, USA | Market Cap: 601m USD | 12M Return: 2.6% | US46436E5289 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.23M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 6 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
The iShares iBonds 2026 Term High Yield and Income ETF (IBHF) is a defined-maturity (target-maturity) ETF that seeks to track an index composed of U.S. dollar-denominated, taxable, fixed-rate corporate bonds. The underlying index includes both below investment-grade (high yield) bonds and BBB-rated bonds-BBB being the lowest tier of investment-grade debt-that are scheduled to mature between January 1, 2026 and December 15, 2026. The fund launched on November 10, 2020 and is issued by BlackRock under its iShares brand.
As a target-maturity product, IBHF is structured to wind up and distribute proceeds as the underlying bonds reach their stated maturity dates, functioning similarly to an individual bond portfolio rather than a perpetual ETF. The combination of below investment-grade and BBB-rated issuers gives the fund exposure to the U.S. speculative-grade corporate bond market, which generally carries higher yields and higher credit risk than investment-grade-only portfolios.
- High yield credit spreads widen on economic slowdown concerns
- Fed rate path impacts bond prices as 2026 maturity approaches
- Fund AUM expands as investors rotate into defined-maturity high yield income
As of November 21, 2026, the stock is trading at USD 22.52 with a total of 217,484 shares traded. Over the past week, the price has changed by +0.07%, over one month by +0.36%, over three months by +1.02% and over the past year by +2.56%.
Current recommended Stop Loss: 22.40 (which is 0.5% or 3 ATR below the current price).
iBonds 2026 Term High Yield has no consensus analysts rating.